Skip to main content
. 2023 Dec 19;13(1):e6820. doi: 10.1002/cam4.6820

FIGURE 2.

FIGURE 2

Kaplan–Meier survival curves of progression‐free survival (PFS) (A) and overall survival (OS) (B) according to anti‐angiogenesis targeted therapy combined with immunotherapy with (n = 42) or without RT (n = 40).